BPC-157 Research Outcomes Tracking: Model Comparison
Tendon/Ligament Injury Tensile strength (Newtons), collagen I:III ratio, inflammatory markers (IL-6, TNF-α) Daily for 7 days, then every 3 days to day 21 Inflammatory reduction by day 3–5, tensile strength improvement by day 14–21 Biomechanical testing is the
This comparison does not assign a generated winner or score.
- Tendon/Ligament Injury
- Tensile strength (Newtons), collagen I:III ratio, inflammatory markers (IL-6, TNF-α)
- Daily for 7 days, then every 3 days to day 21
- Inflammatory reduction by day 3–5, tensile strength improvement by day 14–21
- Biomechanical testing is the gold standard. Histology alone underestimates functional recovery
- Gastric Ulcer/Mucosal Damage
- Ulcer area (mm²), mucosal perfusion (laser Doppler), prostaglandin E2 levels
- Every 48 hours for 14 days
- Ulcer size reduction by day 5–7, complete epithelial coverage by day 10–14
- Perfusion recovery precedes visible epithelial closure. Track both or miss the mechanism
- Wound Healing (Dermal)
- Wound surface area, epithelialization rate, neovascularization (CD31+ density)
- Daily for 10 days, then every 3 days to day 21
- 50% area reduction by day 7–10, complete closure by day 14–18
- Digital planimetry with calibrated imaging is required. Visual estimation has >20% error
- Angiogenesis/Ischemia
- Capillary density (vessels/mm²), VEGF expression, tissue perfusion (contrast micro-CT)
- Every 48–72 hours for 14 days
- VEGF elevation by day 3, new vessel formation by day 7–10
- Functional perfusion lags histological vessel counts by 3–5 days. Measure both